These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 35775474

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
    Koppula P, Zhang Y, Shi J, Li W, Gan B.
    J Biol Chem; 2017 Aug 25; 292(34):14240-14249. PubMed ID: 28630042
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose.
    Joly JH, Delfarah A, Phung PS, Parrish S, Graham NA.
    J Biol Chem; 2020 Jan 31; 295(5):1350-1365. PubMed ID: 31914417
    [Abstract] [Full Text] [Related]

  • 5. High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine/glutamate transporter xCT (SLC7A11).
    Yamaguchi I, Yoshimura SH, Katoh H.
    J Biol Chem; 2020 May 15; 295(20):6936-6945. PubMed ID: 32265299
    [Abstract] [Full Text] [Related]

  • 6. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P, Zhuang L, Gan B.
    Protein Cell; 2021 Aug 15; 12(8):599-620. PubMed ID: 33000412
    [Abstract] [Full Text] [Related]

  • 7. The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility.
    Shin CS, Mishra P, Watrous JD, Carelli V, D'Aurelio M, Jain M, Chan DC.
    Nat Commun; 2017 Apr 21; 8():15074. PubMed ID: 28429737
    [Abstract] [Full Text] [Related]

  • 8. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.
    Lien EC, Ghisolfi L, Geck RC, Asara JM, Toker A.
    Sci Signal; 2017 Dec 19; 10(510):. PubMed ID: 29259101
    [Abstract] [Full Text] [Related]

  • 9. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer.
    Koppula P, Zhang Y, Zhuang L, Gan B.
    Cancer Commun (Lond); 2018 Apr 25; 38(1):12. PubMed ID: 29764521
    [Abstract] [Full Text] [Related]

  • 10. xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling.
    Liu J, Xia X, Huang P.
    Mol Ther; 2020 Nov 04; 28(11):2358-2366. PubMed ID: 32931751
    [Abstract] [Full Text] [Related]

  • 11. The cystine/glutamate antiporter xCT is a key regulator of EphA2 S897 phosphorylation under glucose-limited conditions.
    Teramoto K, Katoh H.
    Cell Signal; 2019 Oct 04; 62():109329. PubMed ID: 31152846
    [Abstract] [Full Text] [Related]

  • 12. Cystine/glutamate antiporter xCT controls skeletal muscle glutathione redox, bioenergetics and differentiation.
    Kanaan MN, Pileggi CA, Karam CY, Kennedy LS, Fong-McMaster C, Cuperlovic-Culf M, Harper ME.
    Redox Biol; 2024 Jul 04; 73():103213. PubMed ID: 38815331
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
    Hasegawa M, Takahashi H, Rajabi H, Alam M, Suzuki Y, Yin L, Tagde A, Maeda T, Hiraki M, Sukhatme VP, Kufe D.
    Oncotarget; 2016 Mar 15; 7(11):11756-69. PubMed ID: 26930718
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification, Expression, and Roles of the Cystine/Glutamate Antiporter in Ocular Tissues.
    Martis RM, Knight LJ, Donaldson PJ, Lim JC.
    Oxid Med Cell Longev; 2020 Mar 15; 2020():4594606. PubMed ID: 32655769
    [Abstract] [Full Text] [Related]

  • 17. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer.
    Liu X, Olszewski K, Zhang Y, Lim EW, Shi J, Zhang X, Zhang J, Lee H, Koppula P, Lei G, Zhuang L, You MJ, Fang B, Li W, Metallo CM, Poyurovsky MV, Gan B.
    Nat Cell Biol; 2020 Apr 15; 22(4):476-486. PubMed ID: 32231310
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Epidermal growth factor promotes glioblastoma cell death under glucose deprivation via upregulation of xCT (SLC7A11).
    Yamamoto M, Teramoto K, Katoh H.
    Cell Signal; 2021 Feb 15; 78():109874. PubMed ID: 33285240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.